Global Hereditary Testing Solution Market Growth (Status and Outlook) 2023-2029

Global Hereditary Testing Solution Market Growth (Status and Outlook) 2023-2029

The global Hereditary Testing Solution market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Hereditary Testing Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Hereditary Testing Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Hereditary Testing Solution is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Hereditary Testing Solution players cover Myriad Genetics, Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc. and Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Hereditary Testing Solution Industry Forecast” looks at past sales and reviews total world Hereditary Testing Solution sales in 2022, providing a comprehensive analysis by region and market sector of projected Hereditary Testing Solution sales for 2023 through 2029. With Hereditary Testing Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hereditary Testing Solution industry.

This Insight Report provides a comprehensive analysis of the global Hereditary Testing Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hereditary Testing Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hereditary Testing Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hereditary Testing Solution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hereditary Testing Solution.

This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Testing Solution market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Oncology
Urology
Imaging
OB/GYN
Others

Segmentation by application
Hospital
Clinic
Laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Myriad Genetics, Inc.
Invitae Corporation
Illumina, Inc.
Natera, Inc.
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated
CooperSurgical, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Medgenome
CENTOGENE
CeGaT
LifeLabs Genetics
Ambry Genetics

Please note: The report will take approximately 2 business days to prepare and deliver.